◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Marvel Biosciences Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024 Q3 2024Jul 31, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Cost Of Revenue 57,457 250,559 382.00 285,002 11,423 --
Gross Profit -57,457 -250,559 -382.00 -285,002 -11,423 --
Selling General And Administration 195,377 229,080 240,710 241,213 209,802 --
General And Administrative Expense 195,377 229,080 240,710 241,213 209,802 --
Other Operating Expenses 10,523 -131,652 34,229 -132,820 10,755 --
Operating Expense 205,900 97,428 274,939 108,393 220,557 --
Operating Income -263,357 -347,987 -275,321 -393,395 -231,980 --
EBIT -285,863 -1.0M -222,759 -449,811 -242,457 --
Interest Expense 56,400 161,771 34,652 35,795 35,788 --
Interest Expense Non Operating 56,400 161,771 34,652 35,795 35,788 --
Interest Income -- 72.00 1,862 -- -- --
Interest Income Non Operating -- 72.00 1,862 -- -- --
Net Interest Income -56,400 -161,699 -32,790 -35,795 -35,788 --
Other Income Expense -22,506 -680,520 50,700 -56,416 -10,477 --
Gain On Sale Of Security -22,506 -8,180 50,700 -56,416 -10,477 --
Pretax Income -342,263 -1.2M -257,411 -485,606 -278,245 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -342,263 -1.2M -257,411 -485,606 -278,245 --
Net Income From Continuing Operation Net Minority Interest -342,263 -1.2M -257,411 -485,606 -278,245 --
Net Income Including Noncontrolling Interests -342,263 -1.2M -257,411 -485,606 -278,245 --
Net Income Common Stockholders -342,263 -1.2M -257,411 -485,606 -278,245 --
Net Income -342,263 -1.2M -257,411 -485,606 -278,245 --
EBITDA -285,863 -1.0M -222,759 -449,811 -242,457 --
Normalized EBITDA -263,357 -947,915 -273,459 -393,395 -231,980 --
Basic EPS -0.01 -- -0.01 -0.01 -0.01 --
Diluted EPS -0.01 -- -0.01 -0.01 -0.01 --
Basic Average Shares 55.6M -- 46.7M 44.8M 44.8M --
Diluted Average Shares 55.6M -- 46.7M 44.8M 44.8M --
Total Unusual Items -22,506 -80,520 50,700 -56,416 -10,477 --
Total Unusual Items Excluding Goodwill -22,506 -80,520 50,700 -56,416 -10,477 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -319,757 -1.1M -308,111 -429,190 -267,768 --
Diluted NI Availto Com Stockholders -342,263 -1.2M -257,411 -485,606 -278,245 --
Net Income Continuous Operations -342,263 -1.2M -257,411 -485,606 -278,245 --
Net Non Operating Interest Income Expense -56,400 -161,699 -32,790 -35,795 -35,788 --
Other Gand A 95,578 125,490 123,412 128,949 102,862 --
Reconciled Cost Of Revenue 57,457 250,559 382.00 285,002 11,423 --
Salaries And Wages 99,799 103,590 117,298 112,264 106,940 --
Selling And Marketing Expense -- -- -- -- 17,750 18,000
Total Expenses 263,357 347,987 275,321 393,395 231,980 --
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024 Q3 2024Jul 31, 2024
Cash And Cash Equivalents 633,536 128,855 389,016 59,530 83,288 --
Cash Cash Equivalents And Short Term Investments 633,536 128,855 389,016 59,530 83,288 --
Cash Financial 633,536 128,855 389,016 59,530 83,288 --
Receivables 25,086 167,549 89,933 133,128 124,840 --
Prepaid Assets 24,434 30,311 21,563 26,417 20,517 --
Current Assets 683,056 326,715 500,512 219,075 228,645 --
Total Non Current Assets 0.00 0.00 0.00 0.00 0.00 --
Total Assets 683,056 326,715 500,512 219,075 228,645 --
Current Debt 2.3M 2.3M 1.0M -- -- 1.7M
Current Debt And Capital Lease Obligation 2.3M 2.3M 1.0M -- -- 1.7M
Accounts Payable 1.6M 1.5M 1.4M 1.7M 1.3M --
Payables 1.6M 1.5M 1.5M 1.8M 1.4M --
Payables And Accrued Expenses 2.0M 2.0M 1.7M 2.1M 1.6M --
Current Accrued Expenses 417,019 522,649 251,069 216,932 181,644 --
Current Liabilities 4.3M 4.3M 2.7M 2.1M 1.6M --
Long Term Debt -- -- 710,000 1.7M 1.7M 1.7M
Long Term Debt And Capital Lease Obligation -- -- 710,000 1.7M 1.7M 1.7M
Total Non Current Liabilities Net Minority Interest 0.00 0.00 710,000 1.7M 1.7M --
Total Liabilities Net Minority Interest 4.3M 4.3M 3.4M 3.8M 3.3M --
Common Stock 9.2M 8.5M 8.4M 7.6M 7.6M --
Capital Stock 9.2M 8.5M 8.4M 7.6M 7.6M --
Additional Paid In Capital -- -- -- -- -- 294,611
Retained Earnings -13.3M -12.9M -11.7M -11.5M -11.0M --
Gains Losses Not Affecting Retained Earnings 450,567 439,673 363,047 333,720 316,093 --
Common Stock Equity -3.7M -4.0M -2.9M -3.5M -3.1M --
Stockholders Equity -3.7M -4.0M -2.9M -3.5M -3.1M --
Total Equity Gross Minority Interest -3.7M -4.0M -2.9M -3.5M -3.1M --
Total Capitalization -3.7M -4.0M -2.2M -1.8M -1.4M --
Net Tangible Assets -3.7M -4.0M -2.9M -3.5M -3.1M --
Tangible Book Value -3.7M -4.0M -2.9M -3.5M -3.1M --
Working Capital -3.7M -4.0M -2.2M -1.8M -1.4M --
Invested Capital -1.3M -1.7M -1.2M -1.8M -1.4M --
Total Debt 2.3M 2.3M 1.7M 1.7M 1.7M --
Net Debt 1.7M 2.2M 1.3M 1.7M 1.6M --
Share Issued 57.5M 53.0M 52.2M 44.8M 44.8M --
Ordinary Shares Number 57.5M 53.0M 52.2M 44.8M 44.8M --
Interest Payable 321,644 286,356 251,069 216,932 181,644 --
Other Current Borrowings 2.3M 2.3M 1.0M -- -- 1.7M
Other Payable -- -- 72,875 93,525 75,375 112,875
Other Receivables -- 150,000 -- -- -- --
Taxes Receivable 25,086 17,549 89,933 133,128 124,840 --
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024 Q3 2024Jul 31, 2024
Operating Cash Flow -178,457 -330,145 -531,314 -26,383 -262,481 --
Cash Flow From Continuing Operating Activities -178,457 -330,145 -531,314 -26,383 -262,481 --
Stock Based Compensation 6,085 17,196 17,658 18,790 21,482 --
Change In Working Capital 150,221 148,025 -291,561 440,433 -5,718 --
Change In Receivables 142,463 -149,956 43,195 -8,288 -8,915 --
Change In Payables And Accrued Expense 1,881 306,729 -339,610 454,621 -5,903 --
Other Non Cash Items 7,500 -- -- -- -- --
Issuance Of Debt -- 0.00 0.00 -- -- 0.00
Net Issuance Payments Of Debt -- 0.00 0.00 -- -- 0.00
Issuance Of Capital Stock -- 93,750 -- -- -- 500,000
Net Common Stock Issuance -- 93,750 -- -- -- 500,000
Financing Cash Flow 683,138 69,984 860,800 2,625 0.00 --
Cash Flow From Continuing Financing Activities 683,138 69,984 860,800 2,625 0.00 --
Changes In Cash 504,681 -260,161 329,486 -23,758 -262,481 --
Beginning Cash Position 128,855 389,016 59,530 83,288 345,769 --
End Cash Position 633,536 128,855 389,016 59,530 83,288 --
Free Cash Flow -178,457 -330,145 -531,314 -26,383 -262,481 --
Change In Prepaid Assets 5,877 -8,748 4,854 -5,900 9,100 --
Common Stock Issuance -- 93,750 -- -- -- 500,000
Long Term Debt Issuance -- -- 0.00 -- -- 0.00
Net Income From Continuing Operations -342,263 -1.2M -257,411 -485,606 -278,245 --
Net Long Term Debt Issuance -- -- 0.00 -- -- 0.00
Net Other Financing Charges -- -23,766 -- -- -- --
Net Short Term Debt Issuance -- 0.00 0.00 -- -- 0.00
Proceeds From Stock Option Exercised 683,138 0.00 0.00 2,625 0.00 --
Short Term Debt Issuance -- 0.00 0.00 -- -- 0.00
NEWS
Loading news...
TRENDING
Loading...